XOMA

XOMA Royalty Corp. XOMA

XOMA
XOMA Royalty Corp. IKNA
Ikena Oncology, Inc. XLO
Xilio Therapeutics, Inc. TARA
Protara Therapeutics, Inc. SRRK
Scholar Rock Holding Corporation AGEN
Agenus Inc. LGND
Ligand Pharmaceuticals Incorporated GERN
Geron Corporation

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode XOMA IKNA XLO TARA SRRK AGEN LGND GERN
6M 82.42 % 2.88 % 12.00 % 33.50 % 40.93 % 133.53 % 70.45 % -5.07 %
YTD 40.12 % -13.33 % -25.79 % -6.45 % -10.64 % 28.48 % 63.93 % -63.61 %
1Y 29.05 % -22.70 % 2.33 % 186.81 % 38.36 % -16.07 % 71.79 % -68.36 %
3Y 117.36 % -70.33 % -66.35 % 43.01 % 442.03 % -92.31 % 91.13 % -44.02 %
5Y 73.06 % -95.53 % -95.04 % -72.31 % 159.26 % -95.58 % 73.48 % -35.47 %
10Y 93.78 % -95.53 % -95.04 % -99.11 % 154.58 % -95.64 % 103.82 % -55.14 %
Depuis le début -99.29 % -95.53 % -95.04 % -98.70 % 154.58 % -99.95 % 287.62 % -82.13 %

Dividende

Ligand Pharmaceuticals Incorporated